DAFNA Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

DAFNA Capital Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-127,585	Closed	-$5.93M	–	82
2023 Q2	$5.93M	Sell	127,585 -60,000	-32%	-$2.07M	1.62%	20
2023 Q1	$5.37M	Buy	187,585 +64,085	+52%	+$1.9M	1.61%	18
2022 Q4	$3.85M	Buy	123,500 +45,000	+57%	+$1.47M	1.09%	29
2022 Q3	$1.59M	Sell	78,500 -78,404	-50%	-$1.43M	0.43%	46
2022 Q2	$2.44M	Buy	156,904 +62,904	+67%	+$1.08M	0.66%	40
2022 Q1	$1.8M	Buy	+94,000	New	+$1.68M	0.47%	50

DAFNA Capital Management's DICE Position: Q3 2023 in Review

DAFNA Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 127,585 shares — an estimated $5.93M sold.

DAFNA Capital Management first reported a position in DICE in Q1 2022 and held it in 6 quarters. The position peaked at $5.93M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

DAFNA Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
DAFNA Capital Management sold 127,585 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $5.93M.
DAFNA Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
DAFNA Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $5.93M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on DAFNA Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.